The 5 Most Interesting Analyst Questions From Waters Corporation’s Q2 Earnings Call
Waters (WAT) Q2 2026 Earnings Call Transcript
Citigroup Maintains Buy on Waters, Raises Price Target to $470
Waters Q2 Earnings Call Highlights
Waters (WAT) Launches Xevo TQ Absolute XR IVD For Clinical Labs
Waters Corporation 2026 Q2 - Results - Earnings Call Presentation
TD Cowen Upgrades Waters (WAT)
Waters Q2 Earnings Beat Estimates, 2026 Revenue Growth View Raised
TD Cowen Upgrades Waters to Buy, Raises Price Target to $475
RBC Capital Maintains Outperform on Waters, Raises Price Target to $475
Evercore ISI Group Maintains Outperform on Waters, Raises Price Target to $420
Wells Fargo Maintains Equal-Weight on Waters, Raises Price Target to $400
Barclays Maintains Overweight on Waters, Raises Price Target to $460
Waters Corporation Q2 2026 Earnings Call Summary
Waters Corp (WAT) (Q2 2026) Earnings Call Highlights: Strong Organic Growth and Raised Guidance ...
Waters Corporation (WAT) Q2 2026 Earnings Call Transcript
Waters (NYSE:WAT) Q2 Results Land Inline with Estimates as Revenue and EPS Edge Past Consensus
Waters (WAT) Q2 Earnings and Revenues Beat Estimates
Waters Corporation (NYSE:WAT) Exceeds Q2 CY2026 Expectations
Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.